Interestingly BRAF mutations occurred only in polyps with the serrated architecture and show a similar frequency with that in MSI CRC, supporting that BRAF activation is pivotal in the serrated pathway of CRC [113–116]. The gene discussed is BRAF; the disease is colorectal carcinoma.